Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Rev Esp Patol ; 55(1): 46-51, 2022.
Artigo em Espanhol | MEDLINE | ID: mdl-34980441

RESUMO

Malakoplakia is a chronic inflammatory process caused by a lysosomal defect in bacterial digestion. Although rare, it occurs more frequently in the genitourinary tract and in patients with immune dysfunction. The bladder is the most commonly affected site, although cases have been reported in other organs, including the prostate gland. Clinically, this lesion can be confused with malignant tumours, both on physical examination and imagining techniques. This is particularly pronounced in the prostate, making the differential diagnosis challenging. Histologically, characteristic aggregates of histiocytes with basophilic intracytoplasmic inclusions composed of calcium and iron salts are found. We present a case diagnosed on transrectal biopsy as acinar adenocarcinoma with a Gleason 5 + 5 = 10 score. Prostatectomy revealed an unusual association of diffuse prostate malakoplakia and an area of acinar adenocarcinoma with a Gleason score of 3 + 4 = 7.


Assuntos
Adenocarcinoma , Malacoplasia , Adenocarcinoma/patologia , Humanos , Malacoplasia/complicações , Malacoplasia/diagnóstico , Malacoplasia/patologia , Masculino , Gradação de Tumores , Próstata/patologia , Prostatectomia/métodos
2.
Rev. esp. patol ; 55(1): 46-51, ene-mar 2022. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-206771

RESUMO

La malacoplaquia es un proceso inflamatorio crónico causado por un defecto lisosomal en la digestión bacteriana. El trastorno, aunque raro, aparece con mayor frecuencia en pacientes con disfunción inmunitaria y en aparato genitourinario. La vejiga es el sitio más comúnmente afectado, aunque se han informado casos con involucro de otros órganos, incluyendo la glándula prostática. Desde una perspectiva clínica, la lesión puede simular tumores malignos durante la exploración física y en estudios de imagen, en particular en próstata, por lo que el diagnóstico diferencial suele ser desafiante. Su expresión morfológica se caracteriza histológicamente por agregados histiocíticos con inclusiones basófilas intracitoplasmáticas, compuestas por sales de calcio y hierro. Se presenta un caso que fue diagnosticado en biopsia transrectal como adenocarcinoma acinar con suma de Gleason 5 + 5 = 10. En la prostatectomía se evidenció la asociación excepcional de malacoplaquia prostática difusa y un foco de adenocarcinoma acinar Gleason 3 + 4 = 7.(AU)


Malakoplakia is a chronic inflammatory process caused by a lysosomal defect in bacterial digestion. Although rare, it occurs more frequently in the genitourinary tract and in patients with immune dysfunction. The bladder is the most commonly affected site, although cases have been reported in other organs, including the prostate gland. Clinically, this lesion can be confused with malignant tumours, both on physical examination and imagining techniques. This is particularly pronounced in the prostate, making the differential diagnosis challenging. Histologically, characteristic aggregates of histiocytes with basophilic intracytoplasmic inclusions composed of calcium and iron salts are found. We present a case diagnosed on transrectal biopsy as acinar adenocarcinoma with a Gleason 5 + 5 = 10 score. Prostatectomy revealed an unusual association of diffuse prostate malakoplakia and an area of acinar adenocarcinoma with a Gleason score of 3 + 4 = 7.(AU)


Assuntos
Humanos , Masculino , Idoso , Malacoplasia , Adenocarcinoma , Neoplasias da Próstata , Prostatectomia , Próstata , Biópsia
3.
Int J Urol ; 27(11): 981-989, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32772434

RESUMO

OBJECTIVES: To determine the well-being of urologists worldwide during the coronavirus disease 2019 pandemic, and whether they have adequate personal protective equipment knowledge and supplies appropriate to their clinical setting. METHODS: Urologists worldwide completed a Société Internationale d'Urologie online survey from 16 April 2020 until 1 May 2020. Analysis was carried out to evaluate their knowledge about protecting themselves and others in the workplace, including their confidence in their ability to remain safe at work, and any regional differences. RESULTS: There were 3488 respondents from 109 countries. Urologists who stated they were moderately comfortable that their work environment offers good protection against coronavirus disease 2019 showed a total mean satisfaction level of 5.99 (on a "0 = not at all" to "10 = very" scale). A large majority (86.33%) were confident about protecting themselves from coronavirus disease 2019 at work. However, only about one-third reported their institution provided the required personal protective equipment (35.78%), and nearly half indicated their hospital has or had limited personal protective equipment availability (48.08%). Worldwide, a large majority of respondents answered affirmatively for testing the healthcare team (83.09%). Approximately half of the respondents (52.85%) across all regions indicated that all surgical team members face an equal risk of contracting coronavirus disease 2019 (52.85%). Nearly one-third of respondents reported that they had experienced social avoidance (28.97%). CONCLUSIONS: Our results show that urologists lack up-to-date knowledge of preferred protocols for personal protective equipment selection and use, social distancing, and coronavirus disease 2019 testing. These data can provide insights into functional domains from which other specialties could also benefit.


Assuntos
COVID-19 , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Exposição Ocupacional/prevenção & controle , Equipamento de Proteção Individual/provisão & distribuição , Gestão da Segurança/organização & administração , Urologistas , COVID-19/epidemiologia , COVID-19/prevenção & controle , Teste para COVID-19/métodos , Teste para COVID-19/estatística & dados numéricos , Saúde Global , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Avaliação das Necessidades , Gestão de Riscos/métodos , Gestão de Riscos/normas , SARS-CoV-2 , Inquéritos e Questionários , Urologistas/normas , Urologistas/estatística & dados numéricos
4.
Can J Urol ; 27(4): 10275-10277, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32861251
5.
Prostate Cancer Prostatic Dis ; 22(1): 24-38, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30131604

RESUMO

BACKGROUND: Androgen deprivation therapy (ADT) is foundational in the management of advanced prostate cancer (PCa) and has benefitted from a recent explosion in scientific advances. These include approval of new therapies that suppress testosterone (T) levels or inactivate its function, improvements in diagnostic and assay technologies, identification of lower therapeutic targets for T, discovery of the relevance of germline genetic mutations and identification of the benefits of sequential and combination therapies. METHODS: This review discusses the clinical profiles of the most up-to-date options for ADT, best practices for managing patients with advanced PCa and future directions in therapy. RESULTS AND CONCLUSIONS: Modern assay technologies reveal that bilateral orchiectomy results in a serum T level of approximately 15 ng/dL as compared to the historical definition of castration of T < 50 ng/dL. Evidence shows that lowering T levels to <20 ng/dL improves patient survival and delays disease progression. Routine monitoring of T in addition to prostate-specific antigen throughout treatment is important to ensure continuing efficacy of T suppression. New drugs that inhibit androgen signaling in combination with traditional ADT suppress T activity to near zero and have significantly improved patient survival. When personalizing ADT regimens physicians should consider a number of factors including initiation and duration of ADT, monitoring of T levels and PSA, the possibility of switching monotherapies if a patient does not achieve adequate T suppression, and consideration of intermittent vs. continuous ADT according to patients' lifestyles, comorbidities, risk factors and tolerance to treatment.


Assuntos
Antagonistas de Androgênios/uso terapêutico , Antineoplásicos Hormonais/uso terapêutico , Terapia de Alvo Molecular , Neoplasias da Próstata/tratamento farmacológico , Antagonistas de Receptores de Andrógenos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Descoberta de Drogas , Humanos , Masculino , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Receptores Androgênicos/metabolismo , Transdução de Sinais/efeitos dos fármacos , Testosterona/metabolismo , Resultado do Tratamento
7.
Med Klin (Munich) ; 105(10): 698-704, 2010 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-20981588

RESUMO

BACKGROUND AND PURPOSE: In the light of increasing resistance to antibiotics used for the treatment of acute urinary tract infections, nitrofurantoin currently experiences a renaissance. Nitrofurantoin shows good efficacy against most bacteria expected in urinary tract infection, and the development of resistance is low. A study on the antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections was conducted in Mexico City, an area where resistance rates of uropathogens to trimethoprim/sulfamethoxazole (cotrimoxazole) are high. PATIENTS AND METHODS: In this open-label, single-arm study 20 adult patients (18 females, 2 males) with positive urine culture were treated orally with nitrofurantoin sustained release 100 mg twice daily for 7 days. Urinary nitrofurantoin concentrations were determined at baseline and day 4 of the study. Primary endpoint was the antimicrobial efficacy of nitrofurantoin at 12 to 16 days after baseline, assessed by changes in urine culture results. RESULTS: In the patient population treated per protocol, primary endpoint analysis revealed a microbial eradication rate of 92.3%. At 35 to 42 days, the eradication rate was 83.3%. At these times, all patients in the per protocol population were free of symptoms. In patients with complicating factors, e.g. diabetic polyneuropathy, both antimicrobial and clinical efficacy appeared to be reduced. Urinary nitrofurantoin concentrations were mostly above minimum inhibitory concentrations of the isolated uropathogens. The study drug was generally well tolerated. Most frequent drug-related adverse event was mild headache, occurring in 10.8% of patients. Two patients discontinued the study due to rash. CONCLUSION: The results of the present study indicate good antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute uncomplicated urinary tract infections as well as acceptable tolerability in adults.


Assuntos
Anti-Infecciosos Urinários/uso terapêutico , Bacteriúria/tratamento farmacológico , Nitrofurantoína/uso terapêutico , Infecções Urinárias/tratamento farmacológico , Administração Oral , Adulto , Idoso , Anti-Infecciosos Urinários/efeitos adversos , Anti-Infecciosos Urinários/farmacocinética , Bacteriúria/urina , Preparações de Ação Retardada , Esquema de Medicação , Feminino , Humanos , Masculino , Taxa de Depuração Metabólica/fisiologia , México , Pessoa de Meia-Idade , Nitrofurantoína/efeitos adversos , Nitrofurantoína/farmacocinética , Recidiva , Resultado do Tratamento , Infecções Urinárias/urina
8.
Urology ; 76(2 Suppl 1): S15-23, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20691881

RESUMO

A comprehensive literature study was conducted to evaluate the levels of evidence (LEs) in publications on the diagnosis and staging of penile cancer. Recommendations from the available evidence were formulated and discussed by the full panel of the International Consultation on Penile Cancer in November 2008. The final grades of recommendation (GRs) were assigned according to the LEs of the relevant publications. The following consensus recommendations were accepted: physical examination of the primary penile lesion is mandatory, evaluating the morphologic and physical characteristics of the lesion (GR A). Evaluation of the primary lesion with ultrasonography is of limited value for local tumor staging (GR C); however, evaluation of the primary tumor with magnetic resonance (MRI) imaging during artificial erection induced by intracavernosal injection of prostaglandin might be more useful (GR B). Histologic or cytologic diagnosis of the primary lesion is mandatory (GR A). For accurate histologic grading and staging, a resected specimen is preferable to a biopsy specimen alone (GR B). Penile cancer should be staged according to the TNM system; however, the 1987/2002 TNM staging system requires revision using data from larger patient cohorts to validate the recently proposed modifications (GR B). The histopathology report should provide information on all prognostic parameters, including the tumor size, histologic type, grade, growth pattern, depth of invasion, tumor thickness, resection margins, and lymphovascular and perineural invasion (GR B). Physical examination of the inguinal and pelvic areas to assess the lymph nodes is mandatory (GR B). Ultrasound-guided fine needle aspiration cytology is indicated for both palpable and nonpalpable inguinal nodes. If the findings confirm lymph node metastasis (LNM), complete inguinal lymph node dissection is indicated (GR B). In patients with nonpalpable inguinal nodes, if the ultrasound-guided fine needle aspiration cytology findings are negative for tumor, dynamic sentinel node biopsy can be performed if the equipment and technical expertise are available (GR C). In patients at high risk of inguinal LNM according to the available guidelines and nomograms, surgical staging can be performed by complete, bilateral inguinal lymph node dissection, which might also be curative (GR B). In patients at intermediate risk of LNM, sentinel node biopsy or modified (limited) inguinal lymph node dissection might be performed (GR B). In patients with nonpalpable inguinal nodes, imaging with computed tomography (CT) or MRI is not indicated, because they are not useful in detecting small-volume LNM. Also, it is very unlikely that large-volume LNM (detectable by CT/MRI) would be present in the pelvic nodes (GR B). In patients with confirmed inguinal LNM, CT of the pelvis is indicated to detect iliac LNMs (GR B). Abdominal CT and chest radiography are advisable if the pelvic CT findings are positive (GR B).


Assuntos
Neoplasias Penianas/diagnóstico , Humanos , Metástase Linfática , Masculino , Estadiamento de Neoplasias , Neoplasias Penianas/patologia , Biópsia de Linfonodo Sentinela
10.
Rev Invest Clin ; 56(5): 572-9, 2004.
Artigo em Espanhol | MEDLINE | ID: mdl-15776859

RESUMO

UNLABELLED: The objective of the present study was to determine the efficacy and safety of a fixed dose of vardenafil in the treatment of patients with erectile dysfunction (ED). MATERIAL AND METHODS: This was an open label, prospective and multicentric trial. After a 4-week wash out period, all patients received 20 mg of vardenafil given on demand for 12 weeks. Primary efficacy variables were the erectile function domain of the International Index of Erectile Function (IIEF), answers to questions 2 and 3 of the Sexual Encounter Profile (SEP) and the Global Assessment Question (GAQ). All adverse events were recorded and reported. RESULTS: 229 patients were screened. 177 received at least one dose of vardenafil and were included in the safety analysis. Mean age was 54.4 years old. Etiology of ED was organic or mixed in 77% of the patients. Erectile function domain of the IIEF changed from a basal mean score of 14.8 to 25.5 at the end of the study. 80.5% of the patients reported erections of rigidity and duration enough for satisfactory sexual intercourse and 93.3% improved their erections at the end of the study. Adverse events were mild to moderate and the most common were headache, dyspepsia, rhinitis and facial flushing. The drop out rate due to adverse events was 1.7%. CONCLUSIONS: This multicenter study confirms the high efficacy of this new phosphodiesterase type 5 inhibitor, vardenafil. There was a low rate of discontinuations due to adverse events and a favorable safety profile. The results of this study are similar to the results of other studies conducted in other parts of the world.


Assuntos
Disfunção Erétil/tratamento farmacológico , Imidazóis/uso terapêutico , Inibidores de Fosfodiesterase/uso terapêutico , Piperazinas/uso terapêutico , Sulfonas/uso terapêutico , Triazinas/uso terapêutico , Adulto , Idoso , Humanos , Masculino , México , Pessoa de Meia-Idade , Estudos Prospectivos , Inquéritos e Questionários , Dicloridrato de Vardenafila
11.
Rev. mex. urol ; 52(5): 115-7, sept.-oct. 1992.
Artigo em Espanhol | LILACS | ID: lil-118445

RESUMO

Con el propósito de difundir mayores conocimientos en torno a la hiperplasia prostática el comité Mexicano para el Estudio de la Próstata se ha dado a la tarea de efectuar una serie de revisiones que en su conjunto logren que el urólogo y el internista puedan diagnosticar y tratar adecuadamente los casos de hiperplasia prostática. En este artículo se hace una completa revisión de la fisiopatogenia de esta afección desde su mecanismo hormonal, teoría de la célula precursora hasta la teoría de la interacción estremo-epitelial.


Assuntos
Humanos , Masculino , Hiperplasia Prostática/fisiopatologia , Neoplasias da Próstata/fisiopatologia , Células-Tronco/metabolismo , Testosterona/efeitos adversos , Substâncias de Crescimento/efeitos adversos , Estradiol/efeitos adversos , Fatores de Crescimento de Fibroblastos/efeitos adversos , Androgênios/efeitos adversos , Estrogênios/efeitos adversos , Mitógenos/efeitos adversos , Próstata/lesões
13.
Rev. invest. clín ; 39(1): 47-52, ene.-mar. 1987. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-69685

RESUMO

Para valorar la utilidad de la tomograía axial computaorizada (TAC) en el diagnóstico y manejo del absceso renal se analizaron en forma retrospectiva 15 casos de absceso renal comparándose este método radiológico con el ultrasonido renal, la urografía excretora y la placa simple de abdomen. La urografía excretora fue diagnósica en el 71.4%, el ultrasonido en el 80%, la placa simple de abdomen en el 33.3% y la TAC en el 100 por ciento. De los 15 pacientes, en 12 el tratamiento fue quirúrgico y en tres casos con servador con antibióticos parenterales. La mortalidad global fue del 16.6 por ciento. Los resultados de nuestro trabajo indican que la TAC es un elemento diagnóstico sensible y superior a los métodos radiológicos convencionales para la detección del absceso renal. Por otro lado, determina con mayor precisión su localización y extensión


Assuntos
Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Abscesso/diagnóstico , Nefropatias/diagnóstico , Tomografia Computadorizada por Raios X , Abscesso , Abscesso/mortalidade , Estudos Retrospectivos , Rim
14.
Rev. invest. clín ; 38(3): 293-6, jul.-sept. 1986. ilus
Artigo em Espanhol | LILACS | ID: lil-104133

RESUMO

Reportamos el caso de un niño de 8 años con criptorquidia bilateral en quien se practicó autotrasplante d eun testículo intr-abdominal utilizando técnica microvascular, con resultado satisfactorio. Se localizó la gónada preoperatoriamente mediante tomografia axial computada. La evaluación de la perfusión testicular postquirúrgica se efectuó con gamagrafía. Diez meses después de la operación el testículo autotrasplantado es normal a la exploración física. Se discuten las indicaciones de este procedimiento, los métodos de evaluación pre y postperatoria y se revisa la literatura. Consideramos que esta técnica es útil cuando la indicación es precisa y sólo si se cuenta con el instrumental y entrenamiento especiales para microcirugía


Assuntos
Criança , Humanos , Masculino , Criptorquidismo/cirurgia , Testículo/transplante , Microcirurgia , Testículo/irrigação sanguínea , Transplante Autólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...